{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:36:03Z","timestamp":1790825763837,"version":"4.1.0"},"reference-count":63,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.1001\/jamaneurol.2019.4443","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T11:31:18Z","timestamp":1577705478000},"page":"441","source":"Crossref","is-referenced-by-count":118,"title":["Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy"],"prefix":"10.1001","volume":"77","author":[{"given":"Angela K.","family":"Birnbaum","sequence":"first","affiliation":[{"name":"Experimental & Clinical Pharmacology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimford J.","family":"Meador","sequence":"additional","affiliation":[{"name":"Department of Neurology & Neurological Sciences, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Karanam","sequence":"additional","affiliation":[{"name":"Experimental & Clinical Pharmacology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Brown","sequence":"additional","affiliation":[{"name":"The Emmes Corporation, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"May","sequence":"additional","affiliation":[{"name":"The Emmes Corporation, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Gerard","sequence":"additional","affiliation":[{"name":"Department of Neurology, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan R.","family":"Gedzelman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Penovich","sequence":"additional","affiliation":[{"name":"Minnesota Epilepsy Group, Saint Paul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Kalayjian","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cavitt","sequence":"additional","affiliation":[{"name":"University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Pack","sequence":"additional","affiliation":[{"name":"Neurology, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Washington, Seattle"},{"name":"Department of Neurological Surgery, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary N.","family":"Stowe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Wisconsin at Madison, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Page B.","family":"Pennell","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the MONEAD Investigator Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"noi190103r1","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1542\/peds.2011-3552","article-title":"Breastfeeding and the use of human milk.","volume":"129","author":"Section on Breastfeeding","year":"2012","journal-title":"Pediatrics"},{"key":"noi190103r3","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1089\/bfm.2009.0050","article-title":"A summary of the Agency for Healthcare Research and Quality\u2019s evidence report on breastfeeding in developed countries.","volume":"4","author":"Ip","year":"2009","journal-title":"Breastfeed Med"},{"issue":"1","key":"noi190103r4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1010539515624964","article-title":"The long-term public health benefits of breastfeeding.","volume":"28","author":"Binns","year":"2016","journal-title":"Asia Pac J Public Health"},{"issue":"5","key":"noi190103r5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023134","article-title":"Is breast feeding associated with offspring IQ at age 5? findings from prospective cohort: Lifestyle During Pregnancy study.","volume":"9","author":"Str\u00f8m","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"noi190103r6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1055\/s-0038-1657766","article-title":"Breastfeeding and the benefits of lactation for women\u2019s health.","volume":"40","author":"Del Ciampo","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"4","key":"noi190103r7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ana.21463","article-title":"Sedative and anticonvulsant drugs suppress postnatal neurogenesis.","volume":"64","author":"Stefovska","year":"2008","journal-title":"Ann Neurol"},{"issue":"2","key":"noi190103r8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.expneurol.2005.01.006","article-title":"Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain.","volume":"193","author":"Manthey","year":"2005","journal-title":"Exp Neurol"},{"issue":"2","key":"noi190103r9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1124\/jpet.107.123133","article-title":"Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain.","volume":"322","author":"Katz","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"noi190103r10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.expneurol.2004.01.025","article-title":"Therapeutic doses of topiramate are not toxic to the developing rat brain.","volume":"187","author":"Glier","year":"2004","journal-title":"Exp Neurol"},{"key":"noi190103r11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/nyas.2003.993.issue-1","article-title":"Antiepileptic drugs and apoptosis in the developing brain.","volume":"993","author":"Bittigau","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"23","key":"noi190103r12","doi-asserted-by":"publisher","first-page":"15089","DOI":"10.1073\/pnas.222550499","article-title":"Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.","volume":"99","author":"Bittigau","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"noi190103r13","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1111\/epi.2017.58.issue-5","article-title":"Placental passage of antiepileptic drugs at delivery and neonatal outcomes.","volume":"58","author":"Bank","year":"2017","journal-title":"Epilepsia"},{"issue":"2","key":"noi190103r14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.0b013e3181a6b325","article-title":"Practice parameter update: management issues for women with epilepsy\u2014focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"issue":"16","key":"noi190103r15","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"noi190103r16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jamapediatrics.2014.118","article-title":"Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.","volume":"168","author":"Meador","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"11","key":"noi190103r17","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2013.4290","article-title":"Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy.","volume":"70","author":"Veiby","year":"2013","journal-title":"JAMA Neurol"},{"issue":"6","key":"noi190103r18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol"},{"key":"noi190103r19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.yebeh.2018.04.009","article-title":"Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy.","volume":"84","author":"Meador","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"1","key":"noi190103r20","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1542\/peds.2007-3812","article-title":"Lamotrigine in breast milk and nursing infants: determination of exposure.","volume":"122","author":"Newport","year":"2008","journal-title":"Pediatrics"},{"issue":"6","key":"noi190103r21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/epi.2007.48.issue-6","article-title":"Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.","volume":"48","author":"Tomson","year":"2007","journal-title":"Epilepsia"},{"issue":"12","key":"noi190103r22","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/00045391-199512000-00011","article-title":"Phenobarbital in sera of epileptic mothers and their infants.","volume":"2","author":"Gomita","year":"1995","journal-title":"Am J Ther"},{"issue":"2","key":"noi190103r23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/acn3.29","article-title":"Model-based lamotrigine clearance changes during pregnancy: clinical implication.","volume":"1","author":"Polepally","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"13","key":"noi190103r24","doi-asserted-by":"publisher","first-page":"e1228","DOI":"10.1212\/WNL.0000000000006240","article-title":"Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy.","volume":"91","author":"Voinescu","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"noi190103r25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1212\/WNL.59.2.251","article-title":"Lamotrigine clearance during pregnancy.","volume":"59","author":"Tran","year":"2002","journal-title":"Neurology"},{"issue":"22, pt 2","key":"noi190103r26","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"noi190103r27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ana.25321","article-title":"Lamotrigine clearance increases by 5 weeks gestational age: relationship to estradiol concentrations and gestational age.","volume":"84","author":"Karanam","year":"2018","journal-title":"Ann Neurol"},{"issue":"9","key":"noi190103r28","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1345\/aph.1C379","article-title":"Prediction of milk\/plasma concentration ratio of drugs.","volume":"37","author":"Larsen","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"4","key":"noi190103r29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/1091581810367949","article-title":"Lactation stage influences drug milk-to-serum values and neonatal exposure risk.","volume":"29","author":"Ling","year":"2010","journal-title":"Int J Toxicol"},{"issue":"2","key":"noi190103r30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/00003088-197601020-00001","article-title":"Clincial pharmacokinetics in neonates.","volume":"1","author":"Morselli","year":"1976","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"noi190103r31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/00003088-198814050-00001","article-title":"Principles of drug biodisposition in the neonate: a critical evaluation of the pharmacokinetic-pharmacodynamic interface (part II).","volume":"14","author":"Besunder","year":"1988","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"noi190103r32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/00003088-198814040-00001","article-title":"Principles of drug biodisposition in the neonate: a critical evaluation of the pharmacokinetic-pharmacodynamic interface (part I).","volume":"14","author":"Besunder","year":"1988","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"noi190103r33","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2165\/00003088-200241120-00003","article-title":"Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.","volume":"41","author":"Alcorn","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"13","key":"noi190103r34","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2165\/00003088-200241130-00005","article-title":"Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.","volume":"41","author":"Alcorn","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"noi190103r35","first-page":"262","article-title":"Developmental pharmacokinetics in pediatric populations.","volume":"19","author":"Lu","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"noi190103r36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/089033402237904","article-title":"Studying drugs in human milk: time to unify the approach.","volume":"18","author":"Begg","year":"2002","journal-title":"J Hum Lact"},{"key":"noi190103r37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1146\/annurev.pa.25.040185.003315","article-title":"Pharmacokinetic pitfalls in the estimation of the breast milk\/plasma ratio for drugs.","volume":"25","author":"Wilson","year":"1985","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"noi190103r38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/cpt.377","article-title":"Modeling drug passage into human milk.","volume":"100","author":"Anderson","year":"2016","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"noi190103r39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/FTD.0b013e3181678ecb","article-title":"High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry.","volume":"30","author":"Subramanian","year":"2008","journal-title":"Ther Drug Monit"},{"key":"noi190103r40","first-page":"46","article-title":"Anticonvulsant drug concentrations in capillary samples collected onto filter paper.","author":"Collins","year":"2005","journal-title":"Epilepsia"},{"issue":"2","key":"noi190103r42","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses.","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"noi190103r43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eplepsyres.2009.02.011","article-title":"Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period.","volume":"85","author":"Fotopoulou","year":"2009","journal-title":"Epilepsy Res"},{"issue":"7-8","key":"noi190103r44","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1345\/aph.1G667","article-title":"Transfer of lamotrigine into breast milk.","volume":"40","author":"Page-Sharp","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"1","key":"noi190103r45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.yebeh.2003.11.018","article-title":"Concerns regarding lamotrigine and breast-feeding.","volume":"5","author":"Liporace","year":"2004","journal-title":"Epilepsy Behav"},{"issue":"6","key":"noi190103r46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/epi.2000.41.issue-6","article-title":"Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation.","volume":"41","author":"Ohman","year":"2000","journal-title":"Epilepsia"},{"issue":"6","key":"noi190103r47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/BF00609630","article-title":"Morphine glucuronidation in human fetal and adult liver.","volume":"22","author":"Pacifici","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"noi190103r48","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1124\/dmd.107.015214","article-title":"Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4.","volume":"35","author":"Miyagi","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"noi190103r49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/epi.2005.46.issue-5","article-title":"Levetiracetam concentrations in serum and in breast milk at birth and during lactation.","volume":"46","author":"Johannessen","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"noi190103r50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults.","volume":"3","author":"Fernandez","year":"2011","journal-title":"Pharmaceutics"},{"issue":"3","key":"noi190103r51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations.","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"noi190103r52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1167.2009.02063.x","article-title":"Abstracts of the 8th European Congress on Epileptology. Berlin, Germany. September 21-25, 2008.","volume":"50","year":"2009","journal-title":"Epilepsia"},{"issue":"3-4","key":"noi190103r53","first-page":"199","article-title":"Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects.","volume":"3","author":"Kuhnz","year":"1983","journal-title":"Pediatr Pharmacol (New York)"},{"key":"noi190103r54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-2006-932618","article-title":"Topiramate used during breast feeding.","volume":"33","author":"Froscher","year":"2006","journal-title":"Aktuelle Neurol"},{"issue":"1","key":"noi190103r55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/jog.2014.40.issue-1","article-title":"Two nursing mothers treated with zonisamide: should breast-feeding be avoided?","volume":"40","author":"Ando","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"noi190103r56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/bfm.2017.0235","article-title":"Maternal carbamazepine therapy and unusual adverse effects in a breastfed infant.","volume":"13","author":"Antonucci","year":"2018","journal-title":"Breastfeed Med"},{"issue":"2","key":"noi190103r57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00004714-199804000-00009","article-title":"Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs.","volume":"18","author":"Wisner","year":"1998","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"noi190103r58","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/JCP.0b013e31815a5819","article-title":"Oxcarbazepine treatment during breast-feeding: a case report.","volume":"27","author":"Lutz","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"noi190103r59","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF00540963","article-title":"Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother.","volume":"34","author":"B\u00fclau","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"noi190103r60","doi-asserted-by":"crossref","DOI":"10.1542\/peds.104.1.e11","article-title":"Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series.","volume":"104","author":"Birnbaum","year":"1999","journal-title":"Pediatrics"},{"issue":"3","key":"noi190103r61","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4088\/JCP.v61n0304","article-title":"Serum valproate levels in 6 breastfeeding mother-infant pairs.","volume":"61","author":"Piontek","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"noi190103r62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0387-7604(01)00407-7","article-title":"Pharmacokinetics of zonisamide in perinatal period.","volume":"24","author":"Kawada","year":"2002","journal-title":"Brain Dev"},{"key":"noi190103r63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0074-7742(08)00014-7","article-title":"Antiepileptic drug therapy in pregnancy II: fetal and neonatal exposure.","volume":"83","author":"Hovinga","year":"2008","journal-title":"Int Rev Neurobiol"},{"key":"noi190103r2","unstructured":"American Academy of Pediatrics. Breastfeeding. https:\/\/www.aap.org\/en-us\/advocacy-and-policy\/aap-health-initiatives\/Breastfeeding\/Pages\/Benefits-of-Breastfeeding.aspx. Published 2019. Accessed December 2, 2019."},{"key":"noi190103r41","unstructured":"Food and Drug Administration. Bioanalytical method validation: guidance for industry. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry Published May 2018. Accessed November 18, 2019."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2758017\/jamaneurology_birnbaum_2019_oi_190103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T11:01:28Z","timestamp":1586775688000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2758017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.4443","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737143862.793569303","asserted-by":"object"}]},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}